Your browser doesn't support javascript.
loading
Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer.
Peng, Shiwen; Wang, Joshua W; Karanam, Balasubramanyam; Wang, Chenguang; Huh, Warner K; Alvarez, Ronald D; Pai, Sara I; Hung, Chien-fu; Wu, T-C; Roden, Richard B S.
Afiliação
  • Peng S; Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Wang JW; Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Karanam B; Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America; Department of Biology and Center for Cancer Research, Carver Research Foundation, Tuskegee University, Tuskegee, Alabama, United States of America.
  • Wang C; Department of Biostatistics, The Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Huh WK; Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Alvarez RD; Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Pai SI; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
  • Hung CF; Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America; Department of Oncology, The Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Wu TC; Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America; Department of Oncology, The Johns Hopkins University, Baltimore, Maryland, United States of America; Department of Gynecology and Obstetrics, The Johns Hopkins University, Baltimore, Maryland, Unite
  • Roden RB; Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America; Department of Oncology, The Johns Hopkins University, Baltimore, Maryland, United States of America; Department of Gynecology and Obstetrics, The Johns Hopkins University, Baltimore, Maryland, Unite
PLoS One ; 10(1): e116389, 2015.
Article em En | MEDLINE | ID: mdl-25560237
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Cisplatino / Infecções por Papillomavirus / Vacinas contra Papillomavirus / Neoplasias Tipo de estudo: Prognostic_studies Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Cisplatino / Infecções por Papillomavirus / Vacinas contra Papillomavirus / Neoplasias Tipo de estudo: Prognostic_studies Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos